Delivery Order SPE2DB20D7061-SPE2DB25FSPH8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,357.60. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Micardis HCT 40-12.5 mg tablet unit dose packages (30 count). This competitive award, valued at $4,145.28 with firm fixed pricing, is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation and represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,243.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose tablets). This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30 count). This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition in the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed price delivery order carries a ceiling value of $3,758.67 and is scheduled for completion by September 3, 2025. The contract represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a ceiling value of $2,783.91. This firm fixed-price delivery order is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30-count) valued at $3,135.92. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award supporting the federal government's pharmaceutical supply requirements. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a $1,318.50 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a period of performance through January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This delivery order, awarded on August 28, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,742.70 under firm fixed price terms. The contract is non-set-aside and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPH8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of MICARDIS HCT 80-25 mg tablets in unit dose packaging (30-count packages) with a ceiling value of $17,061.44. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is set for completion by August 18, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. MICARDIS HCT is a combination antihypertensive medication used in military and federal healthcare systems to manage blood pressure in eligible beneficiaries. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's contract portfolio demonstrates significant capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 8/15/25 |